YY1 and diffuse large B-cell lymphoma: In contrast, high expression of YY1 mRNA was associated with a worse outcome in diffuse large B-cell lymphoma (DLBCL) (Sakhinia et al. 2007) but showed a better outcome in pancreatic cancer (Zhang et al. 2014).